Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,925.00
Bid: 10,800.00
Ask: 11,050.00
Change: -850.00 (-7.30%)
Spread: 250.00 (2.315%)
Open: 10,700.00
High: 10,800.00
Low: 10,625.00
Prev. Close: 11,650.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement and Notice of Final Results

7 Jan 2021 07:00

RNS Number : 8389K
Judges Scientific PLC
07 January 2021
 

 

 Press Release

7 January 2021

 

Judges Scientific plc (the "Group" or "Judges")

Trading Statement and Notice of Final Results

 

The Board of Judges Scientific plc, a group focused on acquiring and developing companies in the scientific instrument sector, provides the following update on the Group's trading performance for the financial year ended 31 December 2020. 

As previously disclosed, following the outbreak of Covid-19 and the subsequent difficult trading conditions associated with lockdowns across the globe, the main impact on the Group has been on order intake which fundamentally drives all other Group key performance metrics. For 2020, year-on-year Organic1 order intake receded by 13%. Notwithstanding this, the Group starts 2021 with a comfortable Organic order book, equivalent to 14.0 weeks of budgeted sales2 (31 December 2019: 13.2 weeks). Strong bookings by the recent acquisitions brings the total order book to 15.5 weeks.

The Group delivered significant profit in each month of 2020 and cash generation remained healthy throughout the period. Exchange rates remained favourable throughout the year in spite of Sterling strengthening in the run-up to the conclusion of a trade deal with the EU. In parallel, the Group continued to deliver on its acquisition strategy with the completion of two acquisitions.

The Group continues to prioritise the safety of its colleagues, and despite the numerous challenges posed by the pandemic, the Group's performance has remained resilient with the second half of the financial year showing a gradual improvement in our trading environment. As a result, the Board anticipates that Adjusted3 Earnings Per Share for the full year ended 31 December 2020 will be ahead of market expectations4.

 

Notice of Final Results

Judges expects to announce its full year results for the year ended 31 December 2020 on 23 March 2021. 

 

Notes:

1. Organic includes those businesses owned by the Group prior to 1 January 2019.

2. The 31 December 2020 Organic order book is approximately £1.8m lower than December 2019 but shows an increase in the number of weeks of budgeted sales as a result of a more prudent FY2021 budget to reflect COVID uncertainty.

3. Adjusted earnings figures are stated before adjusting items relating to hedging of risks materialising after the end of the period, amortisation of acquired intangible assets, share based payments and acquisition-related costs.

4. Market consensus Adjusted Earnings Per Share of 151.8p.

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for making this announcement on behalf of the Company is Brad Ormsby.

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

 

Rebecca Sanders-Hewett

Justine James

Sam Modlin

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 19 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends. 

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDQLFBFFLXBBE
Date   Source Headline
7th Jan 20161:53 pmRNSDirector/PDMR Shareholding
9th Dec 20154:32 pmRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSTotal Voting Rights
16th Nov 201510:58 amRNSBlocklisting Interim Review
6th Nov 20154:57 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:00 amRNSTotal Voting Rights
21st Oct 201512:00 pmRNSNew option schemes, Director/PDMR Shareholding
16th Oct 20153:24 pmRNSDirector/PDMR Shareholding
8th Oct 20155:08 pmRNSDirector/PDMR Shareholding
7th Oct 20152:10 pmRNSDirector/PDMR Shareholding
1st Oct 20157:00 amRNSTotal Voting Rights
28th Sep 20156:00 pmRNSDirector/PDMR Shareholding
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20155:29 pmRNSDirector/PDMR Shareholding
1st Sep 20157:03 amRNSTotal Voting Rights
7th Aug 20157:00 amRNSDirector/PDMR Shareholding
24th Jul 20155:21 pmRNSDirector/PDMR Shareholding and Notice of Results
23rd Jul 20157:00 amRNSTrading Statement
8th Jul 20155:24 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSTotal Voting Rights
8th Jun 20153:00 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSTotal Voting Rights
27th May 20152:18 pmRNSResult of AGM
22nd May 20157:00 amRNSPAYMENT OF DEFERRED CONSIDERATION
13th May 20152:17 pmRNSBlocklisting Application
6th May 20153:35 pmRNSDirector/PDMR Shareholding
29th Apr 201510:40 amRNSExercise of Options
21st Apr 201511:15 amRNSExercise of Options
16th Apr 20151:46 pmRNSIssue of Equity
9th Apr 20154:22 pmRNSDirector/PDMR Shareholding
8th Apr 20155:02 pmRNSDirector/PDMR Shareholding
31st Mar 20155:49 pmRNSDirector/PDMR Shareholding
31st Mar 20157:00 amRNSDirector/PDMR Shareholding
27th Mar 20157:00 amRNSFinal Results
11th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 201512:10 pmRNSNotice of Results
3rd Mar 20157:00 amRNSAppointment of Director and Board transition
10th Feb 20154:26 pmRNSExercise of Options
9th Feb 20155:06 pmRNSDirector/PDMR Shareholding
4th Feb 20155:56 pmRNSHolding(s) in Company
4th Feb 201511:26 amRNSHolding(s) in Company
23rd Jan 201511:45 amRNSDirector/PDMR Shareholding and Exercise of Options
22nd Jan 20154:26 pmRNSDirector/PDMR Shareholding
22nd Jan 20157:00 amRNSAcquisition
20th Jan 20157:00 amRNSTrading Statement
7th Jan 201511:29 amRNSDirector/PDMR Shareholding
23rd Dec 20142:10 pmRNSNew Term Loan and Acquisition Facility
11th Nov 20143:31 pmRNSDirector/PDMR Shareholding
16th Oct 20149:42 amRNSReplacement: Director/PDMR Shareholding
8th Oct 20142:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.